Also found in: Wikipedia.
CT-1Cellular Telephone Standard 1
References in periodicals archive ?
CT-1 is administered orally or by injection; CT-2, a polymer, is applied directly to the exposed blood vessel.
Having achieved in vitro and in vivo proof of principle in preclinical models for CT-1 and CT-2, Atlantic is now actively pursuing corporate partnerships for licensing this technology, including potential rights to all second and subsequent generation compounds.
These preliminary results suggest that CT-1 and CT-2, although not yet in clinical trials, may become useful agents in preventing restenosis.